Surge

French tech company | Builders Republic

About

Medical company that analyzes a patient's immune system before surgery, combining single-cell blood profiling with clinical data and machine learning to predict the risk of postoperative complications — its PreCyte test aims to make major operations safer and guide precision medicine for surgeons.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2021
City
SETE
Region
IDF
Tracked rounds
2
Amount raised
9.7 M€ raised since 2020

Funding rounds

  • Seed — 2024
  • Seed — 2022

Investors